While a recent head-to-head trial of the obesity med heavyweights Wegovy and Zepbound favored the latter drug from Eli Lilly on weight loss, Novo Nordisk has now countered that result with ...

Eli Lilly says its experimental GLP-1 pill helped overweight adults with Type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug in patients ...

The drugmaker Eli Lilly’s reign as the undisputed king of the weight loss trade came under threat in early August, after disappointing preliminary data on its closely watched experimental weight loss ...

INDIANAPOLIS — Eli Lilly & Company and Novo Nordisk announced they are cutting prices on their weight loss drugs in a deal cut with the White House. ”It’s truly an honor to be here today for this ...

Lilly says weight-loss pill meets three out of four criteria for FDA commissioner voucher International Mounjaro sales exceed estimates by nearly $1 billion Third-quarter beat reinforces Lilly lead in ...

i Controlled for family-wise type 1 error rate. ii Percentage of participants achieving body weight reductions of ≥20% with orforglipron 6 mg was not controlled for ...